Akari Therapeutics Plc - ADR
AKTX
Market Cap$18.82K
Close$
$0.00
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18,823.00 |
|---|---|
| Enterprise Value | $-717,177.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-160 |
| Beta | 0.25 |
| Outstanding Shares | 27,294 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.57 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Akari Therapeutics Plc
CEO: David Solomon